Importance of biofilms in medical practice;Importancia de las biopelículas en la práctica médica

Dermatologia Revista Mexicana

Volumn 54, Issue 1, 2010, Pages 14-24

  Rivera, Laura Estela Castrillón ^a   Ramos, Alejandro Palma ^a   Desgarennes, María Del Carmen Padilla ^b  

^a DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

^b CENTRO DERMATOLÓGICO DR LADISLAO DE LA PASCUA   (Mexico)

Author keywords

Antibiotic resistance; Biofilms; Quorum sensing; Wound healing

Indexed keywords

ANTIBIOTIC AGENT; MINOCYCLINE; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BACTERIAL SURVIVAL; BACTERIUM ADHERENCE; BACTERIUM CONTAMINATION; EXTRACELLULAR MATRIX; HOSPITAL INFECTION; MEDICAL PRACTICE; NONHUMAN; REVIEW; WOUND HEALING;

EID: 77949834478     PISSN: 01854038     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Hall-Stoodley L, Costerton WJ, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2004;2:95-108.
2. Costerton JW, Cheng KJ, Geesey GG, et al. Bacterial biofilms in nature and disease. Ann Rev Microbiol 1987;41:435-464.
3. Bos R, van der Mei CH, Busscher JH. Physico-chemistry of initial microbial adhesive interactions. Its mechanisms and methods for study. FEMS Microbiol Rev 1999;23:179-230.
4. Keller L, Surette GM. Communication in bacteria: an ecological and evolutionary perspective. Nat Rev Microbiol 2006;4:249-258.
5. Whitehead AN, Barnard MLA, Slater H, et al. Quorum-sensing in Gram-negative bacteria. FEMS Microbiol Rev 2001;25:365-404.
6. Sutherland WI. Microbial exopolysaccharides-structural subtleties and their consequences. Pure & Appl Chem 1997;69:1911-1917.
7. Sutherland WI. Biofilm exopolysaccharides: a strong and sticky framework. Microbiology 2001;147:3-9.
8. Dunne MW. Bacterial adhesion: seen any good biofilms lately? Clin Microbiol Rev 2002;15(2)155-166.
9. Nazar CJ. Biofilms bacterianos. Rev Otorrinolaringol Cir Cabeza Cuello 2007;67;61-72.
10. Stewart SP, Franklin JM. Physiological heterogeneity in biofilms. Nat Rev Microbiol 2008;6:199-210.
11. Wimpenny J, Manz W, Szewzyk U. Heterogeneity in biofilms. FEMS Microbiol Rev 2000:24:661-671.
12. Ladd TL, Costerton JW. Methods for studding biofilm bacteria. Methods Microbiol 1990;22:285-307.
13. Lawrence JR, Korber DR, Hoyle BD, et al. Optical sectioning of microbial biofilms. J Bacteriol 1991;173:6558-6567.
14. Bloemberg GV, O'Toole GA, Lugtenberg BJJ, Kolter R. Green fluorescent protein as a marker for Pseudomonas spp. Appl Environ Microbiol 1997;63:4543-4551.
15. Leriche V, Sibille P, Carpentier B. Use of enzyme-linked lectinsorbent assay to monitor the shift in polysaccharide composition in bacterial biofilms. Appl Environ Microbiol 66;1851-1856.
16. Djordjevic D, Wiedmann M, McLandsborough LA. Microtiter plate assay for assessment of Lysteria monocytogenes biofilm formation. Appl Environ Microbiol 2002;68:2950-2958.
17. Burton E, Yakandawala N, LoVetri K, Mandhyastha MS. A microplate spectrofluormetric assay for bacterial biofilms. J Ind Microbiol Biotechnol 2007;34:1-4.
18. Xiong YQ, Willard J, Kadurugamuwa JL, et al. Real-time in vivo bioluminescent imaging for evaluating the efficacy of antibiotics in a rat Staphylococcus aureus endocarditis model. Antimicrob Agents Chemother 2005;49:380-387.
19. Mansson LE, Medican K, Molitoris BA, et al. Progression of bacterial infections studied in real time; novel perspectives provided by multiphoton microscopy. Cell Microbiol 2007;9(10):2334-2343.
20. Bryers DJ. Medical biofilms. Biotech Biotechnol 2008;100;1-18.
21. Perencevich EN, Sands KE, Cosgrove SE, et al. Health and economic impact of surgical site infections diagnosed alter hospital discharge. Emerg Infect Dis 2003;9:196-203.
22. Hoiby N. Understanding bacterial biofilms in patients with cystic fibrosis: Current and innovative approaches to potential therapies. J Cyst Fibros 2002;1:249-259.
23. Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clin Microbiol Rev 2002;15:194-222.
24. Moreau-Marquis S, Stanton BA, O'Toole GA. Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway. Pulmonary Pharmacol Ther 2008;21:595-599.
25. Bakaletz LO. Bacterial biofilms in otitis media: Evidence and relevance. Pediatr Infect Dis J 2007;10(Suppl.):S17-S19.
26. Post JC, Hiller NL, Nistico L, et al. The role of biofilms in otolaryngologic infections: Update. Curr Opin Otolaringol Head Neck Surg 2007;15:347-351.
27. Feigin RD, Kline MW, Hyatt SR, Ford KL. Otitis media. In: Feigin RD & Cherry JD, editors. Textbook of pediatric infectious diseases. 3rd ed. Vol. 1. Philadelphia: WB Saunders, 1989;pp:174-189.
28. Bryers JD, Ratner BD. Biomaterials approaches to combating oral biofilms and dental disease. BMC Oral Health 2006;6(Suppl. 1):S15.
29. Offenbacher S, Barros SP, Singer RE, et al. Periodontal disease at the biofilm-gingival interface. J Periodontol 2007;78:1911-1925.
30. Selwitz RH, Ismail AI, Pitts MB. Dental caries. Lancet 2007;369:51-59.
31. Domingue GJ, Hellstrom WJG. Prostatitis. Clin Microbiol Rev 1998;11:604-613.
32. Nickel JC, Costerton JW. Bacterial localization in antibiotic-refractory chronic bacterial prostatitis. Prostate 1993;23:107-114.
33. Wells CJ, Leech GJ, Lever AM, Wansbrough-Jones MH. Treatment of native valve Candida endocarditis with fluconazole. J Infect Dis 1995;31:233-235.
34. nd ed. New York: Raven Press, 1992;pp:85-97.
35. Donlan RM, Costerton JW. Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002;15:167-193.
36. th Congress. Denmark, april 2-5. Abstract 1134-03-427.
37. Wagner C, Obst U, Hänsch GM. Implant-associated posttraumatic osteomyelitis: collateral damage by local host defense? Int J Artif Organs 2005;28:1172-1180.
38. Brady RA, Leid JG, Calhoun JH, et al. Osteomyelitis and the role of biofilms in chronic infection. FEMS Immunol Med Microbiol 2008;52:13-22.
39. Kandemir O, Oztuna V, Milcan A, et al. Clarithromycin destroys biofilms and enhances bactericidal agents in the treatment of Pseudomonas aeruginosa osteomielitis. Clin Orthop Relat Res 2005;430:171-175.
40. Donlan RM. Biofilms and device-associated infections. Emerging Infect Dis 2001;7(2):277-281.
41. Parsek RM, Fuqua C. Biofilms 2003: Emerging themes and challenges in studies of surface-associated microbial life. J Bacteriol 2004;186:3327-4440.
42. Carvalho CCR. Biofilms: recent developments on an old battle. Recent Patents in Biotechnology 2007;1:49-57.
43. Shanks RM, Sargent JL, Martinez RM, et al. Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces. Nephrol Dial Transplant 2006;21:2247-2255.
44. Tunney MM, Jones DS, Gorman SP. Biofilm and biofilm-related encrustation of urinary tract devices. In: Methods in enzymology. San Diego Doyle RJ, editor. Academic Press, 1999;pp:558-566.
45. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999;284:1318-1322.
46. Lewis K. Riddle of biofilm resistance. Antimicrob Agents Chemother 2001;45:999-1007.
47. Gordon CA, Hodges NA, Marriott C. Antibiotic interaction and diffusion through alginate and exopolysaccharide of cystic fibrosis-derived Pseudomonas aeruginosa. J Antimicrob Chemother 1988;22:667-674.
48. Mah TFC, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 2001;9:4-39.
49. Giwercman B, Jensen ETT, Hoiby N, et al. Induction of β-lactamase production in Pseudomonas aeruginosa biofilm. Antimicrob Agents Chemother 1991;35:1008-1010.
50. Brown MR Allison DG, Gilbert P. Resistance of bacterial biofilms to antibiotics: a growth-rate related effect? J Antimicrob Chemother 1988;22:777-780.
51. Lee A, Mao W, Warren MS, et al. Interplay between effux pumps may provide either additive or multiplicative effects on drug resistance. J Bacteriol 2000;182:3142-3150.
52. Moyed HS, Broderick SH. Molecular cloning and expression of hip A, gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol 1986;166:399-403.
53. Percival SL, Bowler P. Biofilms and their potential role in wound healing. Wounds 2004;7:234-240.
54. James GA, Swogger E, Wolcott R, et al. Biofilms in chronic wounds. Wound Repair Regen 2008;16:37-44.
55. Ngo Q, Vickery K, Deva AK. Pr21 role of bacterial biofilms in chronic wounds. ANZ J Surg 2007;77 (Suppl. 1):A66.
56. O'Toole G, Kaplan BH, Kolter R. Biofilm formation as microbial development. Annu Rev Microbiol 2000;54:49-79.
57. Edwards R, Harding KG. Bacteria and wound healing. Curr Opin Infect Dis 2004;17:91-96.
58. Phillips P, Sampson E, Yang Q, et al. Bacterial biofilms in wounds. Wound Healing Southern Africa. 2008;1:10-12.
59. Witte BM, Marbul A. Role of nitric oxide in wound repair. Am J Surg 2002;183:406-412.
60. Fang CF. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 1997;99:2818-2825.
61. Raad I, Hanna H. Intravascular catheters impregnated with antimicrobial agents: a milestone in the prevention of blood-stream infections. Support Care Cancer 1999;7:386-390.
62. Hentzer M, Givskov M. Pharmacological inhibition of quorum sensing for the treatment of chronic bacterial infections. J Clin Invest 2003;112:1300-1307.
63. Balaban N, Cirioni O, Giacometti A, et al. Treatment of Staphylococcus aureus biofilm infection by the Quorum-sensing inhibitor RIP. Antimicrob Agents Chemother 2007;51:2226-2229.
64. Singh KP, Pársec RM, Greenberg EP, Welsh JM. A component of innate immunity prevents bacterial biofilm development. Nature 2002;417:552-555.
65. Rodríguez-Franco DA, Vázquez-Moreno L, Ramos-Clamont Monfort G. Actividad antimicrobiana de la lactoferrina: Mecanismos y aplicaciones clínicas potenciales. Rev Latinoam Microbiol 2005;47:102-111.
66. Johansen Ch, Falholt P, Gram L. Enzymatic removal and disinfection of bacterial biofilms. Appl Environ Microbiol 1997;63:3724-3728.
67. White R. Flaminal® : a novel approach to wound bioburden control. Wounds 2006;2:64-77.
68. Curtin JJ, Donlan RM. Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis. Antimicrob Agents Chemother 2006;50:1268-1275.
69. Lu KT, Collins JJ. Dispersing biofilms with engineered enzymatic bacteriophage. Proc Natl Acad Sci USA 2007;104:11197-11202.